Unknown

Dataset Information

0

Inhibition of DNA Topoisomerase Type II? (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study.

ABSTRACT: In this study, mitoxantrone and its halogenated derivatives have been designed by density functional theory (DFT) to explore their structural and thermodynamical properties. The performance of these drugs was also evaluated to inhibit DNA topoisomerase type II? (TOP2A) by molecular docking calculation. Noncovalent interactions play significant role in improving the performance of halogenated drugs. The combined quantum and molecular mechanics calculations revealed that CF3 containing drug shows better preference in inhibiting the TOP2A compared to other modified drugs.

SUBMITTER: Abu Saleh M 

PROVIDER: S-EPMC4754470 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Inhibition of DNA Topoisomerase Type IIα (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study.

Abu Saleh Md M   Solayman Md M   Hoque Mohammad Mazharol MM   Khan Mohammad A K MA   Sarwar Mohammed G MG   Halim Mohammad A MA  

BioMed research international 20160215

In this study, mitoxantrone and its halogenated derivatives have been designed by density functional theory (DFT) to explore their structural and thermodynamical properties. The performance of these drugs was also evaluated to inhibit DNA topoisomerase type IIα (TOP2A) by molecular docking calculation. Noncovalent interactions play significant role in improving the performance of halogenated drugs. The combined quantum and molecular mechanics calculations revealed that CF3 containing drug shows  ...[more]

Similar Datasets

Unknown Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants.
| S-EPMC3287258 | biostudies-literature
Unknown Inhibition of human DNA topoisomerase II? by two novel ellipticine derivatives.
| S-EPMC4785065 | biostudies-literature
Unknown QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase II?.
| S-EPMC3916431 | biostudies-literature
Unknown Molecular docking analysis of α-Topoisomerase II with δ-Carboline derivatives as potential anticancer agents.
| S-EPMC8340707 | biostudies-literature
Unknown Density Functional Theory, Chemical Reactivity, Pharmacological Potential and Molecular Docking of Dihydrothiouracil-Indenopyridopyrimidines with Human-DNA Topoisomerase II.
| S-EPMC7072893 | biostudies-literature
Unknown Design and synthesis of DNA-intercalative naphthalimide-benzothiazole/cinnamide derivatives: cytotoxicity evaluation and topoisomerase-II? inhibition.
| S-EPMC6350626 | biostudies-literature
Unknown Halogenated imidazole derivatives block RNA polymerase II elongation along mitogen inducible genes.
| S-EPMC2824761 | biostudies-literature
Unknown Expression of the Topoisomerase II Alpha (TOP2A) Gene in Lung Adenocarcinoma Cells and the Association with Patient Outcomes.
| S-EPMC7774312 | biostudies-literature
Unknown Topoisomerase II inhibition involves characteristic chromosomal expression patterns.
| S-EPMC2488358 | biostudies-literature
Unknown Halogenated Flavonoid Derivatives Display Antiangiogenic Activity.
| S-EPMC9331694 | biostudies-literature